Zacks Investment Research on MSN

Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $5.75, demonstrating a -5.89% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily ...

Jim Cramer on Recursion Pharmaceuticals: “Now, It’s a Meme Stock”

Okay, I had Recursion on when they were 9, 10. They did an equity offering. The stock got clobbered. It’s been down.